Bringing CNS Members Together to Make Children’s Lives Better



CNS Research Committee

Daniel Calame, MD, PhD
Baylor College of Medicine


Pediatric neuroscience research is a priority at NINDS. In this webinar, we will discuss a wide range of NINDS funding opportunities for any career stage, from training grants to large, multicenter studies to networks. Mentors are of particular interest because we will discuss diverse and under-represented workforce issues, which are a high priority for NINDS. Basic, translational, and clinical research funding opportunities will be covered, as will domestic and global health. Please join us for a whirlwind tour!

About the Speakers

Adam L. Hartman, MD, FAAN, FAAP, FAES

Dr. Adam Hartman is a Program Director in the Division of Clinical Research with a background in child neurology and epilepsy. Before joining NINDS, he was an Associate Professor of Neurology and Pediatrics at Johns Hopkins School of Medicine, with a joint appointment in the Johns Hopkins Bloomberg School of Public Health Department of Molecular Microbiology and Immunology. He also was Co-Director of the Neurosciences Intensive Care Nursery and Associate Program Director for the Child Neurology residency at Johns Hopkins. Dr. Hartman earned a bachelor’s degree in Chemistry from Northwestern University and an MD from Northwestern University Medical School. During medical school, he was an HHMI-NIH Research Scholar at NIMH. After completing a residency in Pediatrics in the National Capital Uniformed Services Pediatric Residency Program, he served as a general pediatrician in the US Navy for five years (the last as Division Head of General Pediatrics at Naval Medical Center San Diego). He completed his residency in child neurology and a fellowship in clinical neurophysiology/pediatric epilepsy, both at Johns Hopkins. During his training, he studied the mechanism of the ketogenic diet at NINDS. As a faculty member at Johns Hopkins, his lab and clinical research on novel metabolism-based treatments for epilepsy was funded by NIH, the State of Maryland, and private sources. He also has published clinical research in child neurology, with an emphasis on the treatment of medically intractable epilepsy in childhood. His current interests include clinical trials in child neurology, epilepsy, and rare diseases. He is clinically active as a consultant in the Undiagnosed Diseases Program and other select protocols at the NIH Clinical Center.